Page 2 - ஹேண்டா ப்ரொஃபெஸர் ஆஃப் உலகளாவிய ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஹேண்டா ப்ரொஃபெஸர் ஆஃப் உலகளாவிய ஆரோக்கியம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஹேண்டா ப்ரொஃபெஸர் ஆஃப் உலகளாவிய ஆரோக்கியம் Today - Breaking & Trending Today

Biocon posts 19% dip in Q3 net profit as generics biz takes a hit


Biopharmaceutical major Biocon Ltd has posted a nearly 19 per cent dip on a year-on-year (YoY) basis in its consolidated net profit at Rs 186.6 crore for the third quarter of FY21, owing to its generics business taking a hit along with headwinds across operational, regulatory and commercial functions.
The third quarter of the last financial year had seen the Bengaluru-headquartered company post a net profit of Rs 230.3 crore. Biocon s consolidated revenue for Q3 of FY21 increased by 7.20 per cent at Rs 1878.9 crore as against Rs 1752.6 crore for the said quarter last year.
The company s consolidated revenue growth came on the back of a 13 per cent rise in research services and 11 per cent in biosimilar business segments on a YoY basis, along with core earnings before interest, tax, depreciation and amortization (EBITDA) margins of 31 per cent, said Biocon s executive chairperson Kiran Mazumdar-Shaw. ....

Kiran Mazumdar Shaw , Jonathan Hunt , Christiane Hamacher , Siddharth Mittal , Peter Piot , Arun Chandavarkar , Biocon Biologics , London School Of Hygiene Tropical Medicine , Biocon Biologics Ltd , Board Of Biocon Biologics , Goldman Sachs , Handa Professor Of Global Health , Syngene International , Biocon Ltd , Middle East , Offtake Agreement , Insulin Aspart , Biocon Biologic , True North , Tata Capital , Insulin Glargine , London School , Tropical Medicine , Handa Professor , Global Health , Biocon Biologics Limited ,

Biocon Biologics appoints director


With effect from 21 January 2021Biocon Biologics, a subsidiary of Biocon announced today that it has inducted
Professor Peter Piot to its Board as an Independent Director. Professor Piot, MD, PhD is the Director of the London School of Hygiene & Tropical Medicine and the Handa Professor of Global Health.
Professor Piot has been appointed to the board of Biocon Biologics Limited for a period of three years starting 21 January 2021.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these d ....

Peter Piot , Biocon Biologics , London School Of Hygiene Tropical Medicine , Handa Professor Of Global Health , Professor Peter Piot , Professor Piot , London School , Tropical Medicine , Handa Professor , Biocon Biologics Limited , Capital Market , Life Sciences , Hiv Aids Activists , Health Sciences , Companies Based In Bangalore , Hand A , London School Of Hygiene Amp Tropical Medicine , Professor Of Global , பயோகான் உயிரியல் , லண்டன் பள்ளி ஆஃப் சுகாதாரம் வெப்பமண்டல மருந்து , ஹேண்டா ப்ரொஃபெஸர் ஆஃப் உலகளாவிய ஆரோக்கியம் , லண்டன் பள்ளி , வெப்பமண்டல மருந்து , ஹேண்டா ப்ரொஃபெஸர் , பயோகான் உயிரியல் வரையறுக்கப்பட்டவை , மூலதனம் சந்தை ,